###begin article-title 0
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">S&#8414;</xref>
CCCTC-binding Factor Activates PARP-1 Affecting DNA Methylation Machinery*Sâƒž
###end article-title 0
###begin p 1
Both authors contributed equally to this work.
###end p 1
###begin p 2
Present address: Dept. of Experimental Medicine and Pathology, II Faculty of Medicine, University "La Sapienza," 00100 Rome, Italy.
###end p 2
###begin p 3
Supported by Associazione Italiana per la Ricerca sul Cancro fellowship.
###end p 3
###begin p 4
Supported in part by Ministero della Salute.
###end p 4
###begin p 5
###xml 210 232 210 232 <email xmlns:xlink="http://www.w3.org/1999/xlink">caiafa@bce.uniroma1.it</email>
 To whom correspondence should be addressed: Dept. of Cellular Biotechnology and Haematology, University "La Sapienza", viale Regina Elena 324, 00161 Rome, Italy. Tel.: 390649976530; Fax: 390644231961; E-mail: caiafa@bce.uniroma1.it. 
###end p 5
###begin p 6
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 6
###begin p 7
 applies to Author Choice Articles
###end p 7
###begin p 8
###xml 747 755 747 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 889 895 889 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 932 940 932 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 445 450 <span type="species:ncbi:10090">mouse</span>
Our previous data have shown that in L929 mouse fibroblasts the control of methylation pattern depends in part on poly(ADP-ribosyl)ation and that ADP-ribose polymers (PARs), both present on poly(ADP-ribosyl)ated PARP-1 and/or protein-free, have an inhibitory effect on Dnmt1 activity. Here we show that transient ectopic overexpression of CCCTC-binding factor (CTCF) induces PAR accumulation, PARP-1, and CTCF poly(ADP-ribosyl)ation in the same mouse fibroblasts. The persistence in time of a high PAR level affects the DNA methylation machinery; the DNA methyltransferase activity is inhibited with consequences for the methylation state of genome, which becomes diffusely hypomethylated affecting centromeric minor satellite and B1 DNA repeats. In vitro data show that CTCF is able to activate PARP-1 automodification even in the absence of nicked DNA. Our new finding that CTCF is able per se to activate PARP-1 automodification in vitro is of great interest as so far a burst of poly(ADP-ribosyl)ated PARP-1 has generally been found following introduction of DNA strand breaks. CTCF is unable to inhibit DNMT1 activity, whereas poly(ADP-ribosyl)ated PARP-1 plays this inhibitory role. These data suggest that CTCF is involved in the cross-talk between poly(ADP-ribosyl)ation and DNA methylation and underscore the importance of a rapid reversal of PARP activity, as DNA methylation pattern is responsible for an important epigenetic code.
###end p 8
###begin p 9
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 9
###begin p 10
###xml 141 154 141 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 10
###begin p 11
The on-line version of this article (available at ) contains supplemental Experimental Procedures and Fig. S1.
###end p 11
###begin p 12
###xml 216 223 216 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn7">6</xref>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 772 779 772 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 965 972 965 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 974 975 974 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
Over the past decade our laboratory accumulated evidence that links poly(ADP-ribosyl)ation with DNA methylation. A series of different experimental strategies suggests that blockage of poly(ADP-ribosyl)ation induces in vivo DNA hypermethylation. Previous data showed that inhibition of PARP6 activity introduces an anomalous hypermethylated pattern in genomic DNA (1, 2) and in some CpG island regions (3), suggesting that in the absence of ADP-ribose polymers some DNA regions are no longer protected from methylation. Further experiments showed that PARP activity can also affect the methylation pattern of transfected foreign DNA (4). The combined results of these different experimental approaches allowed us to propose the first method to induce DNA hypermethylation in vivo by treatment of cells in culture with PARP activity inhibitors (5) and to study by atomic force microscopy the effect of the addition of new methyl groups to DNA on chromatin structure in vivo (6).
###end p 12
###begin p 13
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
To provide an explanation for how ADP-ribose polymers control and/or protect DNA methylation patterns, several experimental approaches were used. A mechanism has been suggested in which PARP-1 in its poly(ADP-ribosyl)ated isoform makes DNMT1 catalytically inactive and, thus, inefficient in DNA methylation (7). In this model modified PARP-1 is considered as a molecular adaptor of high negative charge onto which chromatin proteins can be attracted and hosted (8). Several proteins show a greater affinity for ADP-ribose polymers than for DNA (9), so that these polymers compete with DNA for binding of these proteins (10). This noncovalent link, which is very strong (11), is not specifically guided by an attraction between charges; proteins showing high affinity for ADP-ribose polymers have an amino acid domain that is responsible for the interaction with these polymers (12). Deeper analysis demonstrated that the affinity of the noncovalent PAR interactions with specific binding proteins depends on the PAR chain length (13).
###end p 13
###begin p 14
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 142 150 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 571 578 571 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 1340 1341 1340 1341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1429 1431 1429 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
Dnmt1 possesses two possible consensus amino acid domains for binding with ADP-ribose polymers and shows a very strong affinity for PARs (7). In vitro experiments have shown that the interaction between DNMT1 and ADP-ribose polymers is stable even in the presence of a 30-fold excess of double strand DNA. Furthermore, the ADP-ribose polymers on automodified PARP-1 almost completely inhibit the catalytic activity of DNMT1, whereas unmodified PARP-1 is not able to inhibit the enzyme. These data, taken together with the facts that PARP-1 and DNMT1 co-immunoprecipitate in vivo and that in this complex PARP-1 is in its modified form (7), suggest that modified PARP-1, trapping DNMT1 through the ADP-ribose polymers, is responsible for the catalytic inactivation of the enzyme in chromatin. This mechanism could be responsible for the protection of the nonmethylated state of CpG islands. In such a scenario, the lack of proper (ADP-ribosyl)ation may lead to new aberrant methylation; in other words, inhibition of PARP activity could allow new methyl groups to be inserted onto DNA. An additional mechanism involved in the functional interplay between PARP and DNA methylation is implied by the observation that inhibition of PARP activity increases both mRNA and protein levels of Dnmt1, the major maintenance methyltransferase, at the G1/S phase border, anomalously increasing the formation of the active complex PCNA-Dnmt1 (14).
###end p 14
###begin p 15
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 846 853 846 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 1019 1021 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1427 1429 1427 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 2029 2031 2029 2031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
To establish whether poly(ADP-ribosyl)ation by itself is involved in the regulation of the promoter region of Dnmt1 gene or of another gene whose product is, in turn, involved in the regulation of Dnmt1 expression, we looked at transcription factors that undergo covalent poly(ADP-ribosyl)ation (15). CTCF, the highly conserved and ubiquitously expressed nuclear factor (16), attracted our attention as this protein, which is one of the major players in imprinting and insulator processes (17), brings together the following two epigenetic events in which we are interested: poly(ADP-ribosyl)ation and DNA methylation. As a chromatin insulator, CTCF links specific consensus sequences located in imprinting control regions. Importantly, it is able to link these regions only if they are unmethylated; furthermore, CTCF binding protects them from de novo methylation (18-20). It has recently been shown that CTCF, in the control of imprinting, binds the consensus sequences in its covalently poly(ADP-ribosyl)ated form (21, 22) (the ADP-ribose polymers, present on the N-terminal region of CTCF, increase its molecular mass from 130 to 180 kDa). The functional importance of poly(ADP-ribosyl)ation in the control of imprinting has been shown by experiments in which treatment of cells with 3-aminobenzamide, a competitive inhibitor of PARP activity, affects insulator function of most of the CTCF target sites. Further studies (23) indicate that following ectopic overexpression of full-length CTCF, the 180-kDa CTCF poly(ADP-ribosyl)ated form localizes to the nucleolus; the use of 3-aminobenzamide suggests that translocation of CTCF to the nucleolus is dependent on poly(ADP-ribosyl)ation, and it is the epigenetic event involved in the control of transcription from rDNA in the nucleolus. The N-terminal domain of CTCF, which is the one that undergoes poly(ADP-ribosyl)ation, seems to be necessary in determining the severe inhibition of cell proliferation and clonogenicity observed following ectopic overexpression of CTCF (24).
###end p 15
###begin p 16
###xml 208 216 208 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 293 299 293 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1</italic>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-2</italic>
###xml 341 342 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 391 392 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 410 416 410 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 457 458 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 492 499 492 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 504 512 504 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 515 516 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 589 594 589 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 639 640 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 786 787 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 821 824 821 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 921 927 921 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 1034 1035 1034 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
Our present data provide, for the first time, evidence that CTCF is involved in the cross-talk between poly(ADP-ribosyl)ation and DNA methylation. Here we show by transient ectopic overexpression of CTCF and in vitro experiments the following. (a) PAR accumulation is increased without higher Parp-1 and Parp-2 mRNA and protein expression. (b) PARP-1 and CTCF become poly(ADP-ribosyl)ated. (c) CTCF is capable per se of activating PARP-1 automodification. (d) CTCF interacts with PARP-1 both in vivo and in vitro. (e) DNA methyltransferase activity is inhibited without down-regulation of Dnmt1 mRNA and/or decrease of its nuclear level. (f) Genomic DNA is diffusely hypomethylated, and severe widespread hypomethylation characterizes both centromeric and B1 repetitive DNA sequences. (g) Overexpression of CTCF in PARP-1-/- cells shows direct involvement of PARP-1 in CTCF-induced PAR synthesis. As CTCF does not affect per se the activity of DNMT1, these data altogether confirm the important role played by PARs on DNMT1 activity (7).
###end p 16
###begin title 17
EXPERIMENTAL PROCEDURES
###end title 17
###begin p 18
###xml 0 42 0 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Culture, Treatments, and Transfection</italic>
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 265 268 265 268 <sc xmlns:xlink="http://www.w3.org/1999/xlink">M L</sc>
###xml 838 839 837 838 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 234 238 <span type="species:ncbi:9913">calf</span>
###xml 655 660 <span type="species:ncbi:9606">human</span>
Cell Culture, Treatments, and Transfection-L929 mouse fibroblasts and A1 mouse embryonic fibroblasts (PARP-1-/-) were maintained as subconfluent culture in high glucose (4.5 g/liter) Dulbecco's modified Eagle's medium, with 10% fetal calf serum (Cambrex Corp.), 2 mM L-glutamine (Cambrex Corp.), and 50 units/ml Pen-Strep (Cambrex Corp.). Exponentially growing cultures were transfected by Lipofectamine Plus reagent (Invitrogen) adopting the manufacturer's protocol with the following plasmid expression vectors: pCI-CTCF-His tag (kindly provided by Elena M. Klenova, Department of Biological Sciences, University of Essex, UK) for the overexpression of human CTCF, pCI-empty vector as control, and pBabe-PURO for selection of transfectants. To obtain hypomethylated DNA, cells were cultivated for 72 h in standard medium containing 5 mum 5-AZA (Sigma).
###end p 18
###begin p 19
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Western Blot Analysis</italic>
###xml 100 101 100 101 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 124 125 124 125 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 188 189 188 189 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 362 363 362 363 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 386 387 386 387 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 392 393 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 398 399 398 399 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 411 412 411 412 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 436 437 436 437 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 604 610 <span type="species:ncbi:9913">bovine</span>
###xml 919 924 <span type="species:ncbi:10090">mouse</span>
###xml 981 986 <span type="species:ncbi:10090">mouse</span>
###xml 1028 1033 <span type="species:ncbi:10090">mouse</span>
###xml 1076 1081 <span type="species:ncbi:10090">mouse</span>
###xml 1118 1124 <span type="species:ncbi:9986">rabbit</span>
###xml 1160 1166 <span type="species:ncbi:9986">rabbit</span>
###xml 1225 1231 <span type="species:ncbi:9986">rabbit</span>
###xml 1273 1277 <span type="species:ncbi:9925">goat</span>
###xml 1283 1288 <span type="species:ncbi:10090">mouse</span>
###xml 1298 1304 <span type="species:ncbi:9986">rabbit</span>
###xml 1305 1316 <span type="species:ncbi:3704">horseradish</span>
Western Blot Analysis-Total cell lysates were obtained by direct lysis of cells in RIPA buffer (50 mm Tris-HCl (pH 8), 150 mm NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 1% Nonidet P-40, 1 mm EDTA). Nuclei were collected from trypsinized and phosphate-buffered saline-washed cells by centrifugation following incubation (30 min) in isolation buffer containing 10 mm Tris-HCl (pH 7.9), 4 mm MgCl2, 1 mm EDTA, 0.5 mm di-thiothreitol, 0.25 mm sucrose, 1% Triton X-100. Nuclear fraction was lysed in RIPA buffer, and protein concentration was determined using the Bradford protein assay reagent (Bio-Rad) with bovine serum albumin (Promega) as standard. Both buffers were supplemented with protease inhibitors (complete EDTA-free, Roche Applied Science). Equal protein amounts were subjected to 6% SDS-PAGE and blotted onto Hybond-ECL nitrocellulose membranes (Amersham Biosciences). The antibodies employed were as follows: mouse monoclonal Ab anti-PARP-1 (C2-10, Alexis Biochemicals), mouse monoclonal Ab anti-PARP-2 (4G8, Alexis), mouse monoclonal Ab anti-PAR (10 HA, Trevigen), mouse monoclonal Ab anti-Dnmt1 (Imgenex), rabbit polyclonal Ab anti-CTCF (Upstate), rabbit polyclonal Ab anti-Sp1 (H-225, Santa Cruz Biotechnology), rabbit polyclonal Ab anti-lamin B1 (AbCam), and goat anti-mouse and anti-rabbit horseradish peroxidase-conjugated antibodies (Santa Cruz Biotechnology).
###end p 19
###begin p 20
###xml 0 41 0 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTCF Expression in the Baculovirus System</italic>
###xml 201 212 192 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Baculovirus</italic>
###xml 531 533 513 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 614 620 <span type="species:ncbi:9913">bovine</span>
CTCF Expression in the Baculovirus System-pVLH-CTCF vector, kindly provided by Dr. Klenova (Department of Biological Sciences, University of Essex), was co-transfected with the BD BaculoGoldtrade mark Baculovirus DNA (BD Biosciences) into SF9 cells. After the co-transfection, the recombinant baculoviruses were selected and amplified following the manufacturer's instructions. The baculovirus recombinant hCTCF His-tagged protein was purified from infected SF9 cells using the Pro-Bondtrade mark purification system (Invitrogen). bvCTCF was quantified by silver staining (SilverQuesttrade mark, Invitrogen) using bovine serum albumin as standard.
###end p 20
###begin p 21
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In Vitro PARP-1 Activity Assay</italic>
###xml 31 33 31 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 207 208 200 201 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 232 233 225 226 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 238 239 231 232 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 245 246 238 239 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 248 249 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 250 251 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 265 266 257 258 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 342 343 333 334 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 421 422 411 412 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 683 685 673 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 853 854 836 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
In Vitro PARP-1 Activity Assay-bvCTCF (0.2, 0.4, or 0.8 pmol) was incubated for 2 h at 30 degreesC with 4 pmol of human recombinant PARP-1 (Alexis) in 200 mul of poly(ADP-ribosyl)ation buffer containing 50 mm Tris-HCl (pH 8.0), 10 mm MgCl2, 10 mm C2H6OS, and 200 mum NAD, in the presence or absence of 200 ng of DNase I-activated DNA or 20 mum PJ-34 (Sigma). PARP-1 automodification reactions with or without PJ-34 (20 mum) were used as control. Reactions were terminated by 20% trichloroacetic acid precipitation, and ADP-ribose synthesis was assayed by 6% SDS-PAGE followed by Western blotting with anti ADP-ribose antibody. An analogous radiometric assay was performed incubating bvCTCF (0.03, 0.05, 0.1, 0.2, 0.4 pmol) for 2 h at 30 degreesC with 1 pmol of human recombinant PARP-1 in 50 mul of poly(ADP-ribosyl)ation buffer and in the presence of [3H]NAD (0.3 muCi). Following 20% trichloroacetic acid precipitation, samples were analyzed in a Beckman LS-6800 liquid scintillation spectrometer.
###end p 21
###begin p 22
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Co-immunoprecipitation (Co-IP)</italic>
###xml 92 93 92 93 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 116 117 116 117 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 129 130 129 130 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 503 509 <span type="species:ncbi:9986">rabbit</span>
###xml 544 549 <span type="species:ncbi:10090">mouse</span>
###xml 589 595 <span type="species:ncbi:9986">rabbit</span>
###xml 647 653 <span type="species:ncbi:9986">rabbit</span>
###xml 657 662 <span type="species:ncbi:10090">mouse</span>
###xml 775 781 <span type="species:ncbi:9913">bovine</span>
Co-immunoprecipitation (Co-IP)-Nuclei obtained from L929 cells were lysed in IP buffer (50 mm Tris-HCl (pH 7.5), 5 mm EDTA, 300 mm NaCl, 1% Nonidet P-40, 1% Triton X-100) supplemented with protease-inhibitors (complete EDTA-free, Roche Applied Science). Lysates (1.5 mg) were pre-cleared with protein A-(for IP anti CTCF and anti PARP-1) or G (for IP anti Dnmt1)-agarose beads (Upstate) on a rotative shaker at 4 degreesC for 2 h and 30 min. Pre-cleared lysates were incubated with specific antibodies (rabbit polyclonal Ab anti-CTCF, Upstate; mouse monoclonal Ab anti-Dnmt1, Imgenex; and rabbit polyclonal Ab anti-PARP-1, Alexis) and with normal rabbit or mouse IgG (Santa Cruz Biotechnology) on a rotative shaker at 4 degreesC. The agarose beads, previously saturated with bovine serum albumin (1 mug/mul) overnight, were added to the lysate/Ab solutions and incubated for 2 h on a rotative shaker at 4 degreesC. Subsequently, beads were washed in IP buffer and boiled in SDS-PAGE sample buffer, and the eluted proteins were analyzed by SDS-PAGE and Western blotting.
###end p 22
###begin p 23
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pulldown Assay</italic>
###xml 178 180 159 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 339 344 <span type="species:ncbi:9606">human</span>
Pulldown Assay-50 mul of ProBondtrade mark resin (Invitrogen) was added to 1.2 ml of 1 x native purification buffer (ProBondtrade mark) in the presence or absence of 0.8 pmol of bvCTCF recombinant His-tagged protein. Mix was incubated overnight on a rotative shaker at 4 degreesC. Then the resin was collected and incubated with 4 pmol of human recombinant PARP-1 (Alexis) in 300 mul of 1 x native purification buffer for 3 h on a rotative shaker at 4 degreesC. After washing the resin with 1x native purification buffer, proteins were eluted from the beads by boiling them in SDS-PAGE sample buffer. Protein-protein interaction was analyzed by 6% SDS-PAGE and Western blot analysis.
###end p 23
###begin p 24
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DNA Methyltransferase Activity</italic>
###xml 345 347 335 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 402 410 392 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 441 443 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 461 466 <span type="species:ncbi:9606">human</span>
###xml 508 513 <span type="species:ncbi:9606">Human</span>
DNA Methyltransferase Activity-Equal amounts of nuclear lysates from cells overexpressing CTCF and relative controls (3-5 mug) were analyzed for the DNA methyltransferase activity by the EpiQuiktrade mark DNA methyltransferase assay kit (Epigentek) following the manufacturer's conditions. This assay was also carried out to check the effect of bvCTCF (0.02, 0.04, and 0.08 pmol) or of same amounts of in vitro poly(ADP-ribosyl)ated PARP-1 (25) on 0.08 pmol of human recombinant DNMT1 (New England Biolabs). Human recombinant PARP-1 (Alexis) (0.08 pmol) was used as control.
###end p 24
###begin p 25
###xml 0 40 0 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNA Extraction and Reverse Transcription</italic>
RNA Extraction and Reverse Transcription-Total RNA (approximately1.8 mug), purified by RNeasy mini kit (Qiagen), was subjected to retrotranscription using Superscript first-strand synthesis system (Invitrogen).
###end p 25
###begin p 26
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Real Time PCR</italic>
###xml 37 52 37 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1, Parp-2,</italic>
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 593 607 593 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1, Parp-2</italic>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 764 769 764 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 895 900 895 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 917 923 917 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1</italic>
###xml 940 946 940 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-2</italic>
###xml 967 972 967 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 109 112 <span type="species:ncbi:9606">Man</span>
Real Time PCR-Expression of mRNA for Parp-1, Parp-2, and Dnmt1 genes was measured by real time PCR using Taq-Man gene expression assays (Applied Biosystems) following the manufacturer's protocol for the absolute standard curve method on iCycler IQ detection system (Bio-Rad). The standard curve was generated using 1:1 serial dilutions (from 100 to 12.5 ng) of cDNA obtained from control at 24 h as reference. PCR efficiency was 90-100% for each set of primers and probe in any experiment. The amplification reaction was performed in duplicate for each sample in 96-well plates. The amount of Parp-1, Parp-2, and Dnmt1 mRNAs was calculated adopting the standard curve method, and normalization was carried out using hypoxanthine-guanine phosphoribosyltransferase (Hprt1) as internal control gene. TaqMan gene expression assay IDs for each set of primers and probe were as follows: Mm00599763m1 (Dnmt1); Mm00500154m1 (Parp-1); Mm00456462m1 (Parp-2); and Mm00446968m1 (Hprt1).
###end p 26
###begin p 27
###xml 0 49 0 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DNA Extraction and Methyl-accepting Ability Assay</italic>
###xml 244 245 243 244 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 269 270 268 269 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 275 276 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 282 283 281 282 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 293 294 292 293 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 440 441 437 438 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 441 442 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 462 466 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">plus</italic>
###xml 482 488 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methyl</italic>
###xml 489 490 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 492 493 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
DNA Extraction and Methyl-accepting Ability Assay-DNA was purified from cells using the DNeasy tissue kit (Qiagen), according to the manufacturer's instructions. Methyl-accepting ability assay was carried out in a final volume of 50 mul of 10 mm Tris-HCl (pH 7.9), 10 mm MgCl2, 50 mm NaCl, 1 mm dithiothreitol in the presence of 1 mug of purified DNA and 1 unit of bacterial SssI methylase (New England Biolabs), using as methyl donor 16 mumS-adenosylmethionine plus 10 muCi/ml of [methyl-3H]S-adenosylmethionine (GE Healthcare; specific activity 70-80 Ci/mmol). The reaction was incubated for 1 h at 37 degreesC and was stopped at 60 degreesC for 30 min after addition of 1% SDS and 250 mug/ml of proteinase K. The incorporation of labeled methyl groups was evaluated on purified DNA in a Beckman LS-6800 liquid scintillation spectrometer.
###end p 27
###begin p 28
###xml 0 44 0 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methylation-sensitive Southern Blot Analysis</italic>
###xml 885 887 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 926 928 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 1121 1122 1113 1114 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Methylation-sensitive Southern Blot Analysis-The DNA methylation level of minor satellite and B1 repeats was evaluated by Southern blot analysis. DNAs (2 mug) were digested with 40 units of MspI or HpaII restriction enzymes for 16 h at 37 degreesC. After 1.5% agarose gel electrophoresis, the digested DNA was blotted on Hybond-N nylon membrane (Amersham Biosciences), and the presence of new HpaII cutting sites was evidenced by hybridization to 3'-digoxigenin-labeled single strand synthetic oligonucleotides as probes. Labeling of probes and detection was performed using digoxigenin oligonucleotide 3'-end labeling kit and digoxigenin luminescent detection kit (Roche Applied Science). Sequence of probes were as follows: for minor satellite repeats, 5'-GGAAACATGATAAAAACCACAGTGTAGAACATATTAGATGAGTGAGTTACACTGAAAAACACATTCGTTGGAAACGGGATTTGTAGAACAGTGTATATCAATGAGTTACAATGAGAAACATC-3' (26); for B1 5'-AGTGAGTTCCAGGACAGCCAG-3' (27). Oligos were made by custom primers synthesis service (Invitrogen). As positive control for DNA demethylation, digestion was performed in parallel on DNA from cells treated for 72 h with 5 mum 5-AZA.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin p 30
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 369 375 369 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 499 500 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 698 699 698 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 930 931 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1049 1050 1049 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1093 1094 1093 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
In the first experimental stage, our attention was focused on describing what happens in L929 fibroblast cells following transient or semi-stable ectopic CTCF overexpression (24) (supplemental Fig. S1A). To quantify the proliferative capacity of CTCF-overexpressing cells, population doublings over time were calculated. We found that control cultures doubled in 1 day versus 3 days for the CTCF-overexpressing one. Cell growth diminished by about 50% at 72 h post-transfection (supplemental Fig. S1B); no substantial change in the distribution of the cell population among the different phases of the cell cycle was observed at this time despite the inhibition of cell growth (supplemental Fig. S1E). Clonogenic ability was also affected when analyzed at 48 h post-transfection of pCI-CTCF plus pBabe-PURO (1:20) and puromycin selection for 2 weeks. At this time the clonogenicity was decreased by about 57% (supplemental Fig. S1D). Unlike previously reported data, CTCF ectopic overexpression increased the percentage of dead (supplemental Fig. S1C) and apoptotic cells (supplemental Fig. S1F).
###end p 30
###begin p 31
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 9 109 9 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the correlation between CTCF and poly(ADP-ribosyl)ation.</bold>
###xml 109 111 109 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAR</italic>
###xml 368 370 368 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1</italic>
###xml 403 409 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-2</italic>
###xml 497 506 497 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 522 530 522 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 541 546 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 635 641 633 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1</italic>
###xml 645 651 643 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-2</italic>
###xml 666 671 664 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 811 822 809 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, in vitro</italic>
###xml 867 869 865 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 939 952 937 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bottom panels</italic>
###xml 1003 1005 1001 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 1227 1229 1212 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 1373 1375 1346 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E,</italic>
###xml 1485 1487 1458 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F,</italic>
###xml 1508 1510 1481 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 9 1551 9 1524 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the correlation between CTCF and poly(ADP-ribosyl)ation.</bold><italic>A,</italic> nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against ADP-ribose polymers (<italic>PAR</italic>) and against the indicated proteins. Sp1 was used as endogenous control. <italic>B,</italic> real time RT-PCR for <italic>Parp-1</italic> and <italic>Parp-2</italic> performed on RNA samples from cells at 24, 48, and 72 h post-transfection of both pCI (<italic>white bar</italic>) and pCI-CTCF (<italic>gray bar</italic>) vectors. <italic>Hprt1</italic> mRNA was used as endogenous control. Data are reported as mean &#177; S.E. of the ratio of <italic>Parp-1</italic> or <italic>Parp-2</italic> mRNA level to <italic>Hprt1</italic> mRNA level within each sample calculated from a minimum of three experiments carried out in duplicate. pCI samples were considered as 1.0. <italic>C, in vitro</italic> assay of PARP-1 activity in the presence of <italic>bv</italic>CTCF. Synthesis of PAR was detected by SDS-PAGE and Western blotting. <italic>Bottom panels</italic> report Western blot analysis for CTCF and PARP-1. <italic>D,</italic> radiometric PARP-1 assay carried out in the presence (&#215;) or in the absence (&#9675;) of &#8220;activated DNA&#8221; and in the presence of PJ-34 (&#9652;). To exclude poly(ADP-ribosyl)ation activity of recombinant CTCF, 0.4 pmol of <italic>bv</italic>CTCF were assayed in poly(ADP-ribosyl)ation buffer (&#9653;). Data are reported as mean &#177; S.E. of two experiments performed in duplicate. <italic>E,</italic> reciprocal Co-IP of CTCF and PARP-1 performed on nuclear lysates. Normal IgGs were used as negative control. <italic>F,</italic> pulldown assay with <italic>bv</italic>CTCF (His-tagged) and recombinant PARP-1.</p>
###xml 9 1551 9 1524 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the correlation between CTCF and poly(ADP-ribosyl)ation.</bold><italic>A,</italic> nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against ADP-ribose polymers (<italic>PAR</italic>) and against the indicated proteins. Sp1 was used as endogenous control. <italic>B,</italic> real time RT-PCR for <italic>Parp-1</italic> and <italic>Parp-2</italic> performed on RNA samples from cells at 24, 48, and 72 h post-transfection of both pCI (<italic>white bar</italic>) and pCI-CTCF (<italic>gray bar</italic>) vectors. <italic>Hprt1</italic> mRNA was used as endogenous control. Data are reported as mean &#177; S.E. of the ratio of <italic>Parp-1</italic> or <italic>Parp-2</italic> mRNA level to <italic>Hprt1</italic> mRNA level within each sample calculated from a minimum of three experiments carried out in duplicate. pCI samples were considered as 1.0. <italic>C, in vitro</italic> assay of PARP-1 activity in the presence of <italic>bv</italic>CTCF. Synthesis of PAR was detected by SDS-PAGE and Western blotting. <italic>Bottom panels</italic> report Western blot analysis for CTCF and PARP-1. <italic>D,</italic> radiometric PARP-1 assay carried out in the presence (&#215;) or in the absence (&#9675;) of &#8220;activated DNA&#8221; and in the presence of PJ-34 (&#9652;). To exclude poly(ADP-ribosyl)ation activity of recombinant CTCF, 0.4 pmol of <italic>bv</italic>CTCF were assayed in poly(ADP-ribosyl)ation buffer (&#9653;). Data are reported as mean &#177; S.E. of two experiments performed in duplicate. <italic>E,</italic> reciprocal Co-IP of CTCF and PARP-1 performed on nuclear lysates. Normal IgGs were used as negative control. <italic>F,</italic> pulldown assay with <italic>bv</italic>CTCF (His-tagged) and recombinant PARP-1.</p></caption>
###xml 1551 1551 1524 1524 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0340845820001"/>
###xml 0 1551 0 1524 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="32"><bold><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the correlation between CTCF and poly(ADP-ribosyl)ation.</bold><italic>A,</italic> nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against ADP-ribose polymers (<italic>PAR</italic>) and against the indicated proteins. Sp1 was used as endogenous control. <italic>B,</italic> real time RT-PCR for <italic>Parp-1</italic> and <italic>Parp-2</italic> performed on RNA samples from cells at 24, 48, and 72 h post-transfection of both pCI (<italic>white bar</italic>) and pCI-CTCF (<italic>gray bar</italic>) vectors. <italic>Hprt1</italic> mRNA was used as endogenous control. Data are reported as mean &#177; S.E. of the ratio of <italic>Parp-1</italic> or <italic>Parp-2</italic> mRNA level to <italic>Hprt1</italic> mRNA level within each sample calculated from a minimum of three experiments carried out in duplicate. pCI samples were considered as 1.0. <italic>C, in vitro</italic> assay of PARP-1 activity in the presence of <italic>bv</italic>CTCF. Synthesis of PAR was detected by SDS-PAGE and Western blotting. <italic>Bottom panels</italic> report Western blot analysis for CTCF and PARP-1. <italic>D,</italic> radiometric PARP-1 assay carried out in the presence (&#215;) or in the absence (&#9675;) of &#8220;activated DNA&#8221; and in the presence of PJ-34 (&#9652;). To exclude poly(ADP-ribosyl)ation activity of recombinant CTCF, 0.4 pmol of <italic>bv</italic>CTCF were assayed in poly(ADP-ribosyl)ation buffer (&#9653;). Data are reported as mean &#177; S.E. of two experiments performed in duplicate. <italic>E,</italic> reciprocal Co-IP of CTCF and PARP-1 performed on nuclear lysates. Normal IgGs were used as negative control. <italic>F,</italic> pulldown assay with <italic>bv</italic>CTCF (His-tagged) and recombinant PARP-1.</p></caption><graphic xlink:href="zbc0340845820001"/></fig>
FIGURE 1.In vivo and in vitro experiments addressing the correlation between CTCF and poly(ADP-ribosyl)ation.A, nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against ADP-ribose polymers (PAR) and against the indicated proteins. Sp1 was used as endogenous control. B, real time RT-PCR for Parp-1 and Parp-2 performed on RNA samples from cells at 24, 48, and 72 h post-transfection of both pCI (white bar) and pCI-CTCF (gray bar) vectors. Hprt1 mRNA was used as endogenous control. Data are reported as mean +/- S.E. of the ratio of Parp-1 or Parp-2 mRNA level to Hprt1 mRNA level within each sample calculated from a minimum of three experiments carried out in duplicate. pCI samples were considered as 1.0. C, in vitro assay of PARP-1 activity in the presence of bvCTCF. Synthesis of PAR was detected by SDS-PAGE and Western blotting. Bottom panels report Western blot analysis for CTCF and PARP-1. D, radiometric PARP-1 assay carried out in the presence (x) or in the absence (o) of "activated DNA" and in the presence of PJ-34 (black triangle). To exclude poly(ADP-ribosyl)ation activity of recombinant CTCF, 0.4 pmol of bvCTCF were assayed in poly(ADP-ribosyl)ation buffer (triangle up). Data are reported as mean +/- S.E. of two experiments performed in duplicate. E, reciprocal Co-IP of CTCF and PARP-1 performed on nuclear lysates. Normal IgGs were used as negative control. F, pulldown assay with bvCTCF (His-tagged) and recombinant PARP-1.
###end p 31
###begin p 32
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the correlation between CTCF and poly(ADP-ribosyl)ation.</bold>
###xml 100 102 100 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 282 285 282 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAR</italic>
###xml 359 361 359 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1</italic>
###xml 394 400 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-2</italic>
###xml 488 497 488 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 513 521 513 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 626 632 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1</italic>
###xml 636 642 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-2</italic>
###xml 657 662 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 802 813 800 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, in vitro</italic>
###xml 858 860 856 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 930 943 928 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bottom panels</italic>
###xml 994 996 992 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 1218 1220 1203 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 1364 1366 1337 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E,</italic>
###xml 1476 1478 1449 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F,</italic>
###xml 1499 1501 1472 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
In vivo and in vitro experiments addressing the correlation between CTCF and poly(ADP-ribosyl)ation.A, nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against ADP-ribose polymers (PAR) and against the indicated proteins. Sp1 was used as endogenous control. B, real time RT-PCR for Parp-1 and Parp-2 performed on RNA samples from cells at 24, 48, and 72 h post-transfection of both pCI (white bar) and pCI-CTCF (gray bar) vectors. Hprt1 mRNA was used as endogenous control. Data are reported as mean +/- S.E. of the ratio of Parp-1 or Parp-2 mRNA level to Hprt1 mRNA level within each sample calculated from a minimum of three experiments carried out in duplicate. pCI samples were considered as 1.0. C, in vitro assay of PARP-1 activity in the presence of bvCTCF. Synthesis of PAR was detected by SDS-PAGE and Western blotting. Bottom panels report Western blot analysis for CTCF and PARP-1. D, radiometric PARP-1 assay carried out in the presence (x) or in the absence (o) of "activated DNA" and in the presence of PJ-34 (black triangle). To exclude poly(ADP-ribosyl)ation activity of recombinant CTCF, 0.4 pmol of bvCTCF were assayed in poly(ADP-ribosyl)ation buffer (triangle up). Data are reported as mean +/- S.E. of two experiments performed in duplicate. E, reciprocal Co-IP of CTCF and PARP-1 performed on nuclear lysates. Normal IgGs were used as negative control. F, pulldown assay with bvCTCF (His-tagged) and recombinant PARP-1.
###end p 32
###begin p 33
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 182 189 182 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 492 493 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 486 493 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 493 504 481 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, top panel</italic>
###xml 758 760 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 1038 1039 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1044 1045 1032 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1030 1045 1018 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>A</italic> and <italic>B</italic></xref>
The extent of poly(ADP-ribosyl)ation was analyzed by Western blots of nuclear proteins obtained from adherent cells ectopically overexpressing CTCF and the respective control cells (Fig. 1A). The use of anti-PAR antibodies showed that CTCF overexpression induced PARP activity, leading to poly(ADP-ribosyl)ation of chromatin proteins, including PARP-1. Anti-CTCF antibodies allowed the identification of the poly(ADP-ribosyl)ated form of CTCF as a band running at approximately180 kDa (Fig. 1A, top panel); it was impossible to detect this band using the anti-ADP-ribose polymer antibodies because the smearing of polymers, which occurs following PARP-1 automodification, covers the molecular weight region corresponding to the 180 kDa of the modified CTCF (21). PARP-1 poly(ADP-ribosyl)ation increased with CTCF overexpression time with a maximum reached at 48 h. Real time PCR and Western blot analyses showed that this increase was not correlated with greater PARP-1 and PARP-2 mRNA levels or with their higher nuclear levels (Fig. 1, A and B).
###end p 33
###begin p 34
###xml 202 204 202 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 334 335 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 328 335 328 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 432 438 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 469 470 468 469 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 724 725 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 718 725 717 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 725 736 724 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, lanes 4&#8211;6</italic>
###xml 757 766 756 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7&#8211;9</italic>
###xml 778 782 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">plus</italic>
###xml 1025 1027 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1028 1030 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1039 1040 1038 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1033 1040 1032 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1040 1049 1039 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, lane 3,</italic>
###xml 1152 1154 1151 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bv</italic>
###xml 1354 1360 1353 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 1734 1735 1732 1733 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1743 1744 1741 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1737 1744 1735 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 1805 1806 1803 1804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1974 1980 1972 1978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 2274 2281 2260 2267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2286 2294 2272 2280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 2305 2306 2291 2292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 2311 2312 2297 2298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 2297 2312 2283 2298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>E</italic> and <italic>F</italic></xref>
###xml 372 377 <span type="species:ncbi:9606">human</span>
To directly test for the effect of CTCF on PARP-1 activity, we used immunometric and radiometric methods. Recombinant PARP-1 was incubated in the presence or absence of different amounts of recombinant bvCTCF under conditions that are typically adopted to induce PARP-1 automodification. The immunometric PARP-1 activity assay (Fig. 1C) was carried out in the presence of human recombinant PARP-1 and DNase I-activated DNA without (lane 1) or with (lane 2) PJ-34 (20 mum), a competitive inhibitor of PARP activity. DNase I-activated DNA is DNA on which some nicks are present, this condition being necessary to induce the poly(ADP-ribosyl)ation of the nick-sensor PARP-1. The reaction was carried out in the presence (Fig. 1C, lanes 4-6) or in the absence (lanes 7-9) of PJ-34, plus addition of increasing amounts of recombinant CTCF (CTCF/PARP-1 molar ratio from 0.05 to 0.2). Finally, PARP activity was assayed following addition of recombinant CTCF (at the same CTCF/PARP-1 molar ratio) but in absence of "activated" DNA (10-12). Fig. 1C, lane 3, reports the reaction carried out in the absence of PARP-1, indicating the absence of PARP activity in bvCTCF preparation. As shown, increasing the molar ratio of CTCF/PARP-1 increased the level of poly(ADP-ribosyl)ation of PARP-1. It was surprising that CTCF acted as an activator of PARP-1 modification per se, being able to induce poly(ADP-ribosyl)ation of PARP-1 even in the absence of nicked DNA, which is required to allow PARP-1 activity. The presence of CTCF reduces the effect of the competitive inhibitor PJ-34, meaning that there may be conformational change of PARP-1. In fact, poly(ADP-ribosyl)ation of PARP-1 was not completely inhibited by a PJ-34 concentration of 20 mum. Fig. 1D refers to the radiometric assay carried out in presence of [3H]NAD. The molar ratio CTCT/PARP-1 of 0.4 increases PARP-1 activity in presence of activated DNA by about 15-fold. This assay confirms the finding that CTCF is capable per se of inducing poly(ADP-ribosyl)ation of PARP-1 even in absence of activated DNA. In fact, the presence of CTCF at 0.4 pmol allows approximately8.5-fold increase in the modification of PARP-1. Co-immunoprecipitation and pulldown experiments have shown that CTCF and PARP-1 directly interact both in vivo and in vitro. (Fig. 1, E and F).
###end p 34
###begin p 35
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 9 121 9 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the effect of CTCF overexpression on DNA methyltransferase activity.</bold>
###xml 121 123 121 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 334 336 334 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 358 363 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 455 464 455 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 479 487 479 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 599 604 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 619 624 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 762 764 760 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 893 901 891 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 912 921 910 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 973 984 971 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D, in vitro</italic>
###xml 1163 1171 1161 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1316 1319 1299 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B&#8211;D</italic>
###xml 1383 1385 1364 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E,</italic>
###xml 9 1494 9 1475 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><bold><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the effect of CTCF overexpression on DNA methyltransferase activity.</bold><italic>A,</italic> nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against CTCF, Dnmt1, and against Sp1 as endogenous control. <italic>B,</italic> real time RT-PCR for <italic>Dnmt1</italic> performed on RNA samples from cells at 24, 48, and 72 h post-transfection with either pCI (<italic>white bar</italic>) or pCI-CTCF (<italic>gray bar</italic>) vectors using <italic>Hprt1</italic> mRNA as endogenous control. Data are reported as mean &#177; S.E. of the arithmetic ratio of <italic>Dnmt1</italic> mRNA level to <italic>Hprt1</italic> mRNA level within each sample calculated from a minimum of three experiments performed in duplicate. pCI samples were considered as 1.0. <italic>C,</italic> endogenous DNA methyltransferase activity of nuclear extract from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF (<italic>gray bar</italic>) and pCI (<italic>white bar</italic>) vectors. The pCI samples were considered as 100%. <italic>D, in vitro</italic> activity assay of recombinant DNMT1 in the presence of increasing amounts of bvCTCF. Data report percentage of DNA methyltransferase 1 activity following addition of bvCTCF (&#8226;), <italic>in vitro</italic> poly(ADP-ribosyl)ated PARP-1 (&#9653;), PARP-1 at a PARP-1/DNMT1 molar ratio of 1 (&#9633;), and CTCF elution buffer (224). Data reported in <italic>B&#8211;D</italic> are mean &#177; S.E. of three experiments performed in duplicate. <italic>E,</italic> reciprocal Co-IP of Dnmt1 and PARP-1 performed on nuclear lysates. Normal IgG were used as negative control.</p>
###xml 9 1494 9 1475 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36"><bold><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the effect of CTCF overexpression on DNA methyltransferase activity.</bold><italic>A,</italic> nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against CTCF, Dnmt1, and against Sp1 as endogenous control. <italic>B,</italic> real time RT-PCR for <italic>Dnmt1</italic> performed on RNA samples from cells at 24, 48, and 72 h post-transfection with either pCI (<italic>white bar</italic>) or pCI-CTCF (<italic>gray bar</italic>) vectors using <italic>Hprt1</italic> mRNA as endogenous control. Data are reported as mean &#177; S.E. of the arithmetic ratio of <italic>Dnmt1</italic> mRNA level to <italic>Hprt1</italic> mRNA level within each sample calculated from a minimum of three experiments performed in duplicate. pCI samples were considered as 1.0. <italic>C,</italic> endogenous DNA methyltransferase activity of nuclear extract from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF (<italic>gray bar</italic>) and pCI (<italic>white bar</italic>) vectors. The pCI samples were considered as 100%. <italic>D, in vitro</italic> activity assay of recombinant DNMT1 in the presence of increasing amounts of bvCTCF. Data report percentage of DNA methyltransferase 1 activity following addition of bvCTCF (&#8226;), <italic>in vitro</italic> poly(ADP-ribosyl)ated PARP-1 (&#9653;), PARP-1 at a PARP-1/DNMT1 molar ratio of 1 (&#9633;), and CTCF elution buffer (224). Data reported in <italic>B&#8211;D</italic> are mean &#177; S.E. of three experiments performed in duplicate. <italic>E,</italic> reciprocal Co-IP of Dnmt1 and PARP-1 performed on nuclear lysates. Normal IgG were used as negative control.</p></caption>
###xml 1494 1494 1475 1475 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0340845820002"/>
###xml 0 1494 0 1475 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="36"><bold><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the effect of CTCF overexpression on DNA methyltransferase activity.</bold><italic>A,</italic> nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against CTCF, Dnmt1, and against Sp1 as endogenous control. <italic>B,</italic> real time RT-PCR for <italic>Dnmt1</italic> performed on RNA samples from cells at 24, 48, and 72 h post-transfection with either pCI (<italic>white bar</italic>) or pCI-CTCF (<italic>gray bar</italic>) vectors using <italic>Hprt1</italic> mRNA as endogenous control. Data are reported as mean &#177; S.E. of the arithmetic ratio of <italic>Dnmt1</italic> mRNA level to <italic>Hprt1</italic> mRNA level within each sample calculated from a minimum of three experiments performed in duplicate. pCI samples were considered as 1.0. <italic>C,</italic> endogenous DNA methyltransferase activity of nuclear extract from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF (<italic>gray bar</italic>) and pCI (<italic>white bar</italic>) vectors. The pCI samples were considered as 100%. <italic>D, in vitro</italic> activity assay of recombinant DNMT1 in the presence of increasing amounts of bvCTCF. Data report percentage of DNA methyltransferase 1 activity following addition of bvCTCF (&#8226;), <italic>in vitro</italic> poly(ADP-ribosyl)ated PARP-1 (&#9653;), PARP-1 at a PARP-1/DNMT1 molar ratio of 1 (&#9633;), and CTCF elution buffer (224). Data reported in <italic>B&#8211;D</italic> are mean &#177; S.E. of three experiments performed in duplicate. <italic>E,</italic> reciprocal Co-IP of Dnmt1 and PARP-1 performed on nuclear lysates. Normal IgG were used as negative control.</p></caption><graphic xlink:href="zbc0340845820002"/></fig>
FIGURE 2.In vivo and in vitro experiments addressing the effect of CTCF overexpression on DNA methyltransferase activity.A, nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against CTCF, Dnmt1, and against Sp1 as endogenous control. B, real time RT-PCR for Dnmt1 performed on RNA samples from cells at 24, 48, and 72 h post-transfection with either pCI (white bar) or pCI-CTCF (gray bar) vectors using Hprt1 mRNA as endogenous control. Data are reported as mean +/- S.E. of the arithmetic ratio of Dnmt1 mRNA level to Hprt1 mRNA level within each sample calculated from a minimum of three experiments performed in duplicate. pCI samples were considered as 1.0. C, endogenous DNA methyltransferase activity of nuclear extract from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF (gray bar) and pCI (white bar) vectors. The pCI samples were considered as 100%. D, in vitro activity assay of recombinant DNMT1 in the presence of increasing amounts of bvCTCF. Data report percentage of DNA methyltransferase 1 activity following addition of bvCTCF (*), in vitro poly(ADP-ribosyl)ated PARP-1 (triangle up), PARP-1 at a PARP-1/DNMT1 molar ratio of 1 (square), and CTCF elution buffer (224). Data reported in B-D are mean +/- S.E. of three experiments performed in duplicate. E, reciprocal Co-IP of Dnmt1 and PARP-1 performed on nuclear lysates. Normal IgG were used as negative control.
###end p 35
###begin p 36
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In vivo</italic> and <italic>in vitro</italic> experiments addressing the effect of CTCF overexpression on DNA methyltransferase activity.</bold>
###xml 112 114 112 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 325 327 325 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 446 455 446 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 470 478 470 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 590 595 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 610 615 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hprt1</italic>
###xml 753 755 751 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 884 892 882 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 903 912 901 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 964 975 962 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D, in vitro</italic>
###xml 1154 1162 1152 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1307 1310 1290 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B&#8211;D</italic>
###xml 1374 1376 1355 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E,</italic>
In vivo and in vitro experiments addressing the effect of CTCF overexpression on DNA methyltransferase activity.A, nuclear lysates from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI were analyzed by SDS-PAGE and Western blot using antibodies against CTCF, Dnmt1, and against Sp1 as endogenous control. B, real time RT-PCR for Dnmt1 performed on RNA samples from cells at 24, 48, and 72 h post-transfection with either pCI (white bar) or pCI-CTCF (gray bar) vectors using Hprt1 mRNA as endogenous control. Data are reported as mean +/- S.E. of the arithmetic ratio of Dnmt1 mRNA level to Hprt1 mRNA level within each sample calculated from a minimum of three experiments performed in duplicate. pCI samples were considered as 1.0. C, endogenous DNA methyltransferase activity of nuclear extract from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF (gray bar) and pCI (white bar) vectors. The pCI samples were considered as 100%. D, in vitro activity assay of recombinant DNMT1 in the presence of increasing amounts of bvCTCF. Data report percentage of DNA methyltransferase 1 activity following addition of bvCTCF (*), in vitro poly(ADP-ribosyl)ated PARP-1 (triangle up), PARP-1 at a PARP-1/DNMT1 molar ratio of 1 (square), and CTCF elution buffer (224). Data reported in B-D are mean +/- S.E. of three experiments performed in duplicate. E, reciprocal Co-IP of Dnmt1 and PARP-1 performed on nuclear lysates. Normal IgG were used as negative control.
###end p 36
###begin p 37
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 101 9 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of DNA methyltransferase activity inhibition on the methylation state of genomic DNA.</bold>
###xml 101 103 101 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref48">48</xref>
###xml 252 260 252 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 270 279 270 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 338 344 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 477 486 477 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bar</italic>
###xml 570 571 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 576 578 574 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 618 619 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 629 630 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 9 904 9 902 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><bold>Effect of DNA methyltransferase activity inhibition on the methylation state of genomic DNA.</bold><italic>A,</italic> methyl-accepting ability assay was carried out on genomic DNA purified from cells transfected for different times (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref48">48</xref>, and 72 h) with pCI-CTCF (<italic>gray bar</italic>) or pCI (<italic>white bar</italic>) vectors. Results are displayed as percentage of activity <italic>versus</italic> relative controls taken as 100. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation (<italic>black bar</italic>). Data are reported as mean &#177; S.E. of three experiments performed in triplicate. <italic>B</italic> and <italic>C,</italic> Southern blot against minor satellite (<italic>B</italic>) and B1 (<italic>C</italic>) DNA repeats performed on genomic DNA purified from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI and digested with HpaII or MspI restriction enzymes. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation.</p>
###xml 9 904 9 902 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38"><bold>Effect of DNA methyltransferase activity inhibition on the methylation state of genomic DNA.</bold><italic>A,</italic> methyl-accepting ability assay was carried out on genomic DNA purified from cells transfected for different times (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref48">48</xref>, and 72 h) with pCI-CTCF (<italic>gray bar</italic>) or pCI (<italic>white bar</italic>) vectors. Results are displayed as percentage of activity <italic>versus</italic> relative controls taken as 100. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation (<italic>black bar</italic>). Data are reported as mean &#177; S.E. of three experiments performed in triplicate. <italic>B</italic> and <italic>C,</italic> Southern blot against minor satellite (<italic>B</italic>) and B1 (<italic>C</italic>) DNA repeats performed on genomic DNA purified from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI and digested with HpaII or MspI restriction enzymes. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation.</p></caption>
###xml 904 904 902 902 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0340845820003"/>
###xml 0 904 0 902 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="38"><bold>Effect of DNA methyltransferase activity inhibition on the methylation state of genomic DNA.</bold><italic>A,</italic> methyl-accepting ability assay was carried out on genomic DNA purified from cells transfected for different times (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref48">48</xref>, and 72 h) with pCI-CTCF (<italic>gray bar</italic>) or pCI (<italic>white bar</italic>) vectors. Results are displayed as percentage of activity <italic>versus</italic> relative controls taken as 100. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation (<italic>black bar</italic>). Data are reported as mean &#177; S.E. of three experiments performed in triplicate. <italic>B</italic> and <italic>C,</italic> Southern blot against minor satellite (<italic>B</italic>) and B1 (<italic>C</italic>) DNA repeats performed on genomic DNA purified from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI and digested with HpaII or MspI restriction enzymes. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation.</p></caption><graphic xlink:href="zbc0340845820003"/></fig>
FIGURE 3.Effect of DNA methyltransferase activity inhibition on the methylation state of genomic DNA.A, methyl-accepting ability assay was carried out on genomic DNA purified from cells transfected for different times (24, 48, and 72 h) with pCI-CTCF (gray bar) or pCI (white bar) vectors. Results are displayed as percentage of activity versus relative controls taken as 100. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation (black bar). Data are reported as mean +/- S.E. of three experiments performed in triplicate. B and C, Southern blot against minor satellite (B) and B1 (C) DNA repeats performed on genomic DNA purified from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI and digested with HpaII or MspI restriction enzymes. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation.
###end p 37
###begin p 38
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of DNA methyltransferase activity inhibition on the methylation state of genomic DNA.</bold>
###xml 92 94 92 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref48">48</xref>
###xml 243 251 243 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 261 270 261 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 329 335 329 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 468 477 468 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bar</italic>
###xml 561 562 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 567 569 565 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 609 610 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 620 621 618 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
Effect of DNA methyltransferase activity inhibition on the methylation state of genomic DNA.A, methyl-accepting ability assay was carried out on genomic DNA purified from cells transfected for different times (24, 48, and 72 h) with pCI-CTCF (gray bar) or pCI (white bar) vectors. Results are displayed as percentage of activity versus relative controls taken as 100. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation (black bar). Data are reported as mean +/- S.E. of three experiments performed in triplicate. B and C, Southern blot against minor satellite (B) and B1 (C) DNA repeats performed on genomic DNA purified from cultures at 24, 48, and 72 h post-transfection with pCI-CTCF and pCI and digested with HpaII or MspI restriction enzymes. DNA obtained from cells treated with 5-AZA was used as positive control for genome hypomethylation.
###end p 38
###begin p 39
###xml 712 713 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 706 713 706 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 737 738 737 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 731 738 731 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 773 774 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 767 774 767 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 899 905 899 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 968 976 968 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1023 1031 1023 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1152 1153 1152 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 1162 1163 1162 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1156 1163 1156 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 1309 1316 1309 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1324 1325 1324 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1318 1325 1318 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>E</italic></xref>
###xml 1358 1359 1358 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 1244 1249 <span type="species:ncbi:10090">mouse</span>
Our knowledge that DNA methylation and poly(ADP-ribosyl)ation are connected prompted us to further investigate the scenario where the ectopic overexpression of CTCF induced a burst of PARs and poly(ADP-ribosyl)ation of PARP-1, which remained high in time. We expected that this condition would induce permanent inhibition of Dnmt1 and consequently genomic DNA hypomethylation. We thus tested whether the increased amount of modified PARP-1 influenced the endogenous DNA methyltransferase activity. The activity assay, carried out on nuclear extracts obtained from cells ectopically overexpressing CTCF and the respective control cells, showed that DNA methyltransferase activity decreased by about 65-70% (Fig. 2C). Real time PCR (Fig. 2B) and Western blot analyses (Fig. 2A) excluded that inhibition of enzymatic activity was dependent on down-regulation of Dnmt1 levels. The possibility that CTCF per se was acting as an inhibitor of DNMT1 activity was disproved by in vitro assays; parallel experiments carried out with in vitro poly(ADP-ribosyl)ated PARP-1 confirmed that poly(ADP-ribosyl)ated PARP-1 is responsible for inhibitory effect on DNMT1 (7) (Fig. 2D). Co-immunoprecipitation experiments, carried out on nuclear extracts from L929 mouse fibroblasts, indicate that PARP-1 and Dnmt1 are associated in vivo (Fig. 2E), confirming our previous data (7).
###end p 39
###begin p 40
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 300 301 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 738 739 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 744 746 744 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 730 746 730 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>B</italic> and <italic>C,</italic></xref>
###xml 1296 1299 1296 1299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1353 1356 1353 1356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1470 1473 1470 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;C</italic>
###xml 1462 1473 1462 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>A&#8211;C</italic></xref>
###xml 1653 1654 1653 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1647 1654 1647 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 325 330 <span type="species:ncbi:9606">human</span>
###xml 1300 1305 <span type="species:ncbi:10090">mouse</span>
Research was then focused on DNA methylation pattern and the possibility that inhibition of Dnmt1 activity leads to DNA hypomethylation. Fig. 3A reports data from methyl-accepting ability assays, carried out on DNA purified from cells overexpressing CTCF and control cells in the presence of labeled S-adenosylmethionine and human recombinant DNMT1. CTCF overexpression introduced hypomethylation on genomic DNAs, and as a result, its methyl-accepting ability increased 3-fold at 24 h from transfection. The integrity and the amounts of purified genomic DNA were evaluated by agarose gel electrophoresis (data not shown). Southern blot analyses were performed on the same DNA samples to localize the new hypomethylated sequences. Fig. 3, B and C, reports experiments in which genomic DNA, previously digested with methylation-sensitive HpaII restriction enzyme and with its insensitive isoschizomer MspI, was analyzed, after electrophoretic separation of DNA fragments, by using 3'-digoxigenin-labeled single strand synthetic oligonucleotides as probes. As can be seen, both centromeric and B1 repetitive DNA sequences were hypomethylated. To verify how specific the PARP-1 poly(ADP-ribosyl)ation is in affecting DNA methylation activity, we performed experiments of CTCF overexpression in PARP-1-/- mouse cells. Ectopic overexpression of CTCF in PARP-1-/- cells did not reduce the DNA methyltransferase activity, Dnmt1 level, and the cell growth significantly (Fig. 4, A-C and supplemental Experimental Procedures), although it induces a moderate increase of PARs because of an enhanced activity of PARP-2 and/or of other members of PARP family (Fig. 4A).
###end p 40
###begin p 41
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 9 141 9 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of CTCF overexpression in PARP-1<sup>&#8211;/&#8211;</sup> cells on PARs level, cell survival, Dnmt1 expression, and DNA methyltransferase activity.</bold>
###xml 141 143 141 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 405 407 405 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 477 486 477 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 502 510 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 521 523 521 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 627 636 627 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 652 660 652 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 688 689 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 694 695 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 9 747 9 745 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><bold>Effect of CTCF overexpression in PARP-1<sup>&#8211;/&#8211;</sup> cells on PARs level, cell survival, Dnmt1 expression, and DNA methyltransferase activity.</bold><italic>A,</italic> nuclear lysates from L929 and A1 (PARP-1<sup>&#8211;/&#8211;</sup>) cells at 72 h post-transfection with pCI and pCI-CTCF vectors were analyzed by SDS-PAGE and Western blotting, using antibodies against PAR and against the indicated proteins. Lamin B1 was used as endogenous control. <italic>B,</italic> survival of L929 and A1 cells after 72 h post-transfection with pCI (<italic>white bar</italic>) and pCI-CTCF (<italic>gray bar</italic>) vectors. <italic>C,</italic> endogenous Dnmt activity of nuclear lysates from L929 and A1 cells at 72 h post-transfection with pCI (<italic>white bar</italic>) and pCI-CTCF (<italic>gray bar</italic>) vectors. Data reported in <italic>B</italic> and <italic>C</italic> are mean &#177; S.E. of three independent experiments.</p>
###xml 9 747 9 745 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42"><bold>Effect of CTCF overexpression in PARP-1<sup>&#8211;/&#8211;</sup> cells on PARs level, cell survival, Dnmt1 expression, and DNA methyltransferase activity.</bold><italic>A,</italic> nuclear lysates from L929 and A1 (PARP-1<sup>&#8211;/&#8211;</sup>) cells at 72 h post-transfection with pCI and pCI-CTCF vectors were analyzed by SDS-PAGE and Western blotting, using antibodies against PAR and against the indicated proteins. Lamin B1 was used as endogenous control. <italic>B,</italic> survival of L929 and A1 cells after 72 h post-transfection with pCI (<italic>white bar</italic>) and pCI-CTCF (<italic>gray bar</italic>) vectors. <italic>C,</italic> endogenous Dnmt activity of nuclear lysates from L929 and A1 cells at 72 h post-transfection with pCI (<italic>white bar</italic>) and pCI-CTCF (<italic>gray bar</italic>) vectors. Data reported in <italic>B</italic> and <italic>C</italic> are mean &#177; S.E. of three independent experiments.</p></caption>
###xml 747 747 745 745 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0340845820004"/>
###xml 0 747 0 745 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="42"><bold>Effect of CTCF overexpression in PARP-1<sup>&#8211;/&#8211;</sup> cells on PARs level, cell survival, Dnmt1 expression, and DNA methyltransferase activity.</bold><italic>A,</italic> nuclear lysates from L929 and A1 (PARP-1<sup>&#8211;/&#8211;</sup>) cells at 72 h post-transfection with pCI and pCI-CTCF vectors were analyzed by SDS-PAGE and Western blotting, using antibodies against PAR and against the indicated proteins. Lamin B1 was used as endogenous control. <italic>B,</italic> survival of L929 and A1 cells after 72 h post-transfection with pCI (<italic>white bar</italic>) and pCI-CTCF (<italic>gray bar</italic>) vectors. <italic>C,</italic> endogenous Dnmt activity of nuclear lysates from L929 and A1 cells at 72 h post-transfection with pCI (<italic>white bar</italic>) and pCI-CTCF (<italic>gray bar</italic>) vectors. Data reported in <italic>B</italic> and <italic>C</italic> are mean &#177; S.E. of three independent experiments.</p></caption><graphic xlink:href="zbc0340845820004"/></fig>
FIGURE 4.Effect of CTCF overexpression in PARP-1-/- cells on PARs level, cell survival, Dnmt1 expression, and DNA methyltransferase activity.A, nuclear lysates from L929 and A1 (PARP-1-/-) cells at 72 h post-transfection with pCI and pCI-CTCF vectors were analyzed by SDS-PAGE and Western blotting, using antibodies against PAR and against the indicated proteins. Lamin B1 was used as endogenous control. B, survival of L929 and A1 cells after 72 h post-transfection with pCI (white bar) and pCI-CTCF (gray bar) vectors. C, endogenous Dnmt activity of nuclear lysates from L929 and A1 cells at 72 h post-transfection with pCI (white bar) and pCI-CTCF (gray bar) vectors. Data reported in B and C are mean +/- S.E. of three independent experiments.
###end p 41
###begin p 42
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 0 132 0 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of CTCF overexpression in PARP-1<sup>&#8211;/&#8211;</sup> cells on PARs level, cell survival, Dnmt1 expression, and DNA methyltransferase activity.</bold>
###xml 132 134 132 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 175 178 175 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 396 398 396 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 468 477 468 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 493 501 493 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 512 514 512 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 618 627 618 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bar</italic>
###xml 643 651 643 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bar</italic>
###xml 679 680 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
Effect of CTCF overexpression in PARP-1-/- cells on PARs level, cell survival, Dnmt1 expression, and DNA methyltransferase activity.A, nuclear lysates from L929 and A1 (PARP-1-/-) cells at 72 h post-transfection with pCI and pCI-CTCF vectors were analyzed by SDS-PAGE and Western blotting, using antibodies against PAR and against the indicated proteins. Lamin B1 was used as endogenous control. B, survival of L929 and A1 cells after 72 h post-transfection with pCI (white bar) and pCI-CTCF (gray bar) vectors. C, endogenous Dnmt activity of nuclear lysates from L929 and A1 cells at 72 h post-transfection with pCI (white bar) and pCI-CTCF (gray bar) vectors. Data reported in B and C are mean +/- S.E. of three independent experiments.
###end p 42
###begin title 43
DISCUSSION
###end title 43
###begin p 44
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
This research emphasizes the importance of proper dynamics between poly(ADP-ribose) polymerase and poly(ADP-ribose) glycohydrolase (PARG) activities so that cellular homeostasis is not affected by low or excessively high PAR levels. In physiological conditions, the active, poly(ADP-ribosyl)ated PARP-1 molecules constitute a small proportion of the total population of PARP-1 molecules, whereas upon injury to the cell, the number of active PARP-1 molecules increases causing an up to 500 times higher level of PARs (28). In this environment PARP-1 plays an important role as it is responsible for about 90% of PAR production (29). However, the basal level of polymers is rapidly restored thanks to the intervention of PARG (30-32), which shuttles from the cytoplasm to the nucleus (33, 34), digesting the excess of nuclear PARs in a few minutes (28, 35).
###end p 44
###begin p 45
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 117 9 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A possible model describing the sequence of events occurring in cells following CTCF ectopic overexpression.</bold>
###xml 134 144 134 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray arrow</italic>
###xml 9 519 9 519 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46"><bold>A possible model describing the sequence of events occurring in cells following CTCF ectopic overexpression.</bold> CTCF activates (<italic>gray arrow</italic>) PARP-1 inducing its automodification and poly(ADP-ribosyl)ation of CTCF and of other nuclear proteins yet to be identified. The persistence of PARs in the nuclear environment induces &#8220;stable&#8221; inhibition of Dnmt1 activity. Modified PARP-1, binding noncovalently the Dnmt1, inhibits its enzymatic activity, and as a consequence, the genomic DNA becomes widely hypomethylated.</p>
###xml 9 519 9 519 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46"><bold>A possible model describing the sequence of events occurring in cells following CTCF ectopic overexpression.</bold> CTCF activates (<italic>gray arrow</italic>) PARP-1 inducing its automodification and poly(ADP-ribosyl)ation of CTCF and of other nuclear proteins yet to be identified. The persistence of PARs in the nuclear environment induces &#8220;stable&#8221; inhibition of Dnmt1 activity. Modified PARP-1, binding noncovalently the Dnmt1, inhibits its enzymatic activity, and as a consequence, the genomic DNA becomes widely hypomethylated.</p></caption>
###xml 519 519 519 519 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0340845820005"/>
###xml 0 519 0 519 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="46"><bold>A possible model describing the sequence of events occurring in cells following CTCF ectopic overexpression.</bold> CTCF activates (<italic>gray arrow</italic>) PARP-1 inducing its automodification and poly(ADP-ribosyl)ation of CTCF and of other nuclear proteins yet to be identified. The persistence of PARs in the nuclear environment induces &#8220;stable&#8221; inhibition of Dnmt1 activity. Modified PARP-1, binding noncovalently the Dnmt1, inhibits its enzymatic activity, and as a consequence, the genomic DNA becomes widely hypomethylated.</p></caption><graphic xlink:href="zbc0340845820005"/></fig>
FIGURE 5.A possible model describing the sequence of events occurring in cells following CTCF ectopic overexpression. CTCF activates (gray arrow) PARP-1 inducing its automodification and poly(ADP-ribosyl)ation of CTCF and of other nuclear proteins yet to be identified. The persistence of PARs in the nuclear environment induces "stable" inhibition of Dnmt1 activity. Modified PARP-1, binding noncovalently the Dnmt1, inhibits its enzymatic activity, and as a consequence, the genomic DNA becomes widely hypomethylated.
###end p 45
###begin p 46
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A possible model describing the sequence of events occurring in cells following CTCF ectopic overexpression.</bold>
###xml 125 135 125 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray arrow</italic>
A possible model describing the sequence of events occurring in cells following CTCF ectopic overexpression. CTCF activates (gray arrow) PARP-1 inducing its automodification and poly(ADP-ribosyl)ation of CTCF and of other nuclear proteins yet to be identified. The persistence of PARs in the nuclear environment induces "stable" inhibition of Dnmt1 activity. Modified PARP-1, binding noncovalently the Dnmt1, inhibits its enzymatic activity, and as a consequence, the genomic DNA becomes widely hypomethylated.
###end p 46
###begin p 47
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 798 799 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref44">44</xref>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 1181 1183 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 1185 1187 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref46">46</xref>
Over the years, it has been shown that the decrease and increase of PAR level can both threaten the normal cellular physiology. Treatment of cells with competitive inhibitors of PARP activity has demonstrated that delay in DNA damage repair and genomic instability occur when nuclear levels of PARs are low (36). Research on cells knocked out for PARP-1 (37) or PARP-2 (38), the two best-known members of the PARP family (39), has indicated that both enzymes are involved in the mechanism of DNA damage repair: knocking out of either enzyme is not lethal, whereas the cell cannot survive the double knock-outs (38). Likewise harmful is the accumulation of PARs, which is even perceived as a signal for cell death (40-42). Cell death, observed when PAR level is high, has long been attributed to NAD+ depletion and thus to energy insufficiency (43). Without excluding that more than one event leads to cellular death, it has been shown that PARs by themselves cause cell mortality (44). Cytoplasmic long and branched polymers (41), interacting with mitochondrial membrane stimulate the release of the pro-apoptotic factor AIF, an apoptotic signal downstream of PARP activation (42, 45, 46).
###end p 47
###begin p 48
###xml 254 260 254 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
In the above-mentioned research attention was focused on what happens to the cell when high levels of PARs are present in the cytosol. We have focused our attention on events that occur in the nucleus. Based on our experimental data, we suggest a model (Fig. 5) that depicts the order in which molecular events take place. The starting point is when the increased nuclear level of CTCF induces a higher level of nuclear PARs. It is surprising that at all observation times, 24, 48, and 72 h following ectopic transfection of CTCF, the nuclear level of PARs remained high not depending on an increased PARP-1 expression, even though the PAR level returns to basal level in a few minutes following stress (28).
###end p 48
###begin p 49
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref48">48</xref>
###xml 368 375 368 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 380 388 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
In vitro experiments show that CTCF is by itself capable of activating PARP-1. This activation happens even in absence of activated DNA, and this is different from YY1 (47) and VP1 (48). Furthermore, the effect of the PJ-34 inhibitor is diminished in presence of CTCF. Co-immunoprecipitation and pulldown experiments confirmed interaction between CTCF and PARP-1 both in vivo and in vitro.
###end p 49
###begin p 50
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 550 558 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 734 735 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 972 975 972 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
Our previous data show that both free PARs and PARs present on modified PARP-1, through a noncovalent interaction with DNMT1, inhibit its enzymatic activity. Here we investigated whether prolonged elevated PAR levels could stably inhibit the activity of Dnmt1. We show that DNA methyltransferase activity is decreased by about 70% in nuclear extract in cells overexpressing CTCF versus cells transfected with empty vector. A more thorough examination of Dnmt1 has shown that the inhibition is not because of a decreased level of Dnmt1 expression. An in vitro approach allowed us to exclude direct inhibition of DNMT1 activity by CTCF, in line with our previous observation that PARs present on modified PARP-1 inhibit DNMT1 activity (7). The persistence of a high PAR level affects the DNA methylation machinery; Dnmt1 activity is inhibited, leading to wide hypomethylation of the genome, involving both centromeric and B1 repeats. Ectopic overexpression of CTCF in PARP-1-/- cells demonstrates a specific functional relationship between CTCF and PARP-1.
###end p 50
###begin p 51
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref50">50</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref53">53</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref54">54</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
This finding underscores the importance of a rapid reversal of PARP-1 automodification because is affects DNA methylation patterns considered to be part of the epigenetic code. DNA hypomethylation could decondense chromatin structure (49, 50), cause genomic instability (51), direct cells toward apoptosis (52), and cancer (53, 54). The unusual cellular environment, in which a large amount of ADP-ribose polymers are present for several days, mimics the situation in PARG knock-outs and provides a model for the study of damage because of excess of ADP-ribose polymers in cells. Our data suggest that deregulation of DNA methylation pattern is one of the molecular mechanisms causing lethality in PARG knock-out mice (40).
###end p 51
###begin p 52
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref54">54</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref56">56</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref55">55</xref>
The finding that high PAR levels induce hypomethylation is intriguing, because in tumor cells the hypomethylation of repeat-rich heterochromatin contributes to genomic instability, through increased mitotic recombination events (51). The introduction of new methyl groups onto DNA or the diffuse hypomethylation in cancer cells (54, 56) could occur through deregulation of PARP or PARG activities. This demethylation is a passive mechanism (55) that does not depend on decreased expression of Dnmt1 but on the absence of an active Dnmt1.
###end p 52
###begin p 53
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref57">57</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 1069 1070 1069 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 1207 1208 1207 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 1209 1210 1209 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
In the cellular scenario dependent on ectopic overexpression of CTCF, the cytotoxicity is accounted for by a decreased level of intracellular NAD+ (43), whereas the increased number of apoptotic cells can be explained by recent data showing that the higher ADP-ribose polymer production (57) and DNA hypomethylation (52) induce apoptosis. The connection between DNA methylation and poly(ADP-ribosyl)ation inferred from our previous studies (1-6) is strengthened by our new findings showing that activation of PARP-1, dependent on CTCF, affects DNA methylation machinery. It is clear that, because of the complexity of pathways that occur in cells, despite evidence showing the connection between poly-ADP-ribosylated PARP-1 and Dnmt1, other additional and/or alternative mechanism(s) cannot be excluded. Based on our extensive research on poly(ADP-ribosyl)ation and DNA methylation, we think that the control of DNA methylation pattern is among the multiple housekeeping roles of PARP-1; this role could be played by the inhibitory effect exerted by PARs on the Dnmt1 (7). The balance of PARs constitutively present in cells may be extremely important; their decrease causes anomalous DNA hypermethylation (1-6), whereas their increase leads to widespread DNA hypomethylation.
###end p 53
###begin p 54
Further research will be carried out to define in depth the role played by CTCF in the cross-talk between poly(ADP-ribosyl)ation and DNA methylation and to establish whether and how the normal functions of PARG are affected in this new cellular scenario. We will assess whether CTCF represses PARG expression, inhibits its enzymatic activity, or impairs its physiological shuttling from the cytoplasm to the nucleus.
###end p 54
###begin title 55
Supplementary Material
###end title 55
###begin title 56
[Supplemental Data]
###end title 56
###begin p 57
The abbreviations used are: PARP, poly(ADP-ribose) polymerase; CTCF, CCCTC-binding factor; PAR, poly(ADP-ribose); Dnmt1, DNA methyltransferase 1; 5-AZA, 5-azacytidine; IP, immunoprecipitation; Co-IP, co-immunoprecipitation; Ab, antibody; PARG, poly(ADP-ribose) glycohydrolase.
###end p 57

